Paper Details

  1. Home
  2. Paper Details

Treatment of first-attack genital herpes--acyclovir versus inosine pranobex.

Author: Allason-JonesE, BartonI, FahertyA, JeavonsM, KinghornG, MindelA, PatouG, WilliamsP, WoolleyP

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.

Overview

A study of 77 patients with first-time genital herpes found that acyclovir was more effective than inosine pranobex in reducing symptoms and viral shedding.
Paper Details　
Original Abstract of the Article :
77 patients with a first attack of genital herpes were entered into a double-blind trial to compare the efficacy of acyclovir with that of inosine pranobex. 24 patients received acyclovir with that of inosine pranobex, and 28 both drugs. Patients treated with acyclovir or both drugs healed more quic...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/s0140-6736(87)92144-1

データ提供：米国国立医学図書館（NLM）

Acyclovir vs. Inosine Pranobex for Genital Herpes

Herpes simplex virus (HSV) is a common infection that can cause painful sores, particularly in the genital area. Finding effective treatments for this persistent virus is a key challenge in the field of infectious diseases. This research compares the effectiveness of two antiviral drugs, acyclovir and inosine pranobex, in treating first-attack genital herpes. Think of it as comparing two different sets of tools in the fight against this pesky virus.

The Verdict: Acyclovir Emerges as a Better Weapon

The study, published in the British Journal of Dermatology, involved 77 patients with a first episode of genital herpes. The results showed that acyclovir, either alone or in combination with inosine pranobex, was more effective in promoting healing and reducing viral shedding. The study found that patients treated with acyclovir healed more quickly and experienced shorter periods of viral shedding compared to those treated with inosine pranobex alone. The authors suggest that acyclovir is the preferred treatment option for first-attack genital herpes.

Navigating the Herpes Desert

Finding effective treatments for HSV is like finding a reliable oasis in a vast desert. This research provides valuable information for healthcare professionals and individuals seeking effective treatment options. Remember, if you experience symptoms of genital herpes, it's important to consult with your doctor for appropriate diagnosis and treatment.

Dr.Camel's Conclusion

When it comes to fighting the herpes virus, acyclovir emerges as a more effective weapon than inosine pranobex, helping to reduce the duration of viral shedding and promote faster healing. This study provides valuable insights for healthcare professionals in choosing the most effective treatment for first-attack genital herpes. It's a reminder that even in the vast desert of medical knowledge, we can find tools to combat persistent viruses and improve patient outcomes.

Date :
  1. Date Completed 1987-06-24
  2. Date Revised 2019-06-10
Further Info :

Pubmed ID

2437417

DOI: Digital Object Identifier

10.1016/s0140-6736(87)92144-1

Related Literature

Article Analysis
・Effective treatment of genital herpes
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.